Consumer activist groups have censured the silicone breast implants of the Johnson & Johnson group due to its doubtful long-term safety effects.

In the Food and Drug Administration’s consultative summit the activist group raised their concerns over the J&J implant products which were out in the market.

The silicone gel breast implants products were approved by FDA in the year 2006 and it was decided that the companies will look at its effects on the 40,000 women over the period of next decade.

J&J and Allergan received the FDA approval and it has been notified that Allergan has disclosed its data of two years, of around 60% of partakers’ and J&J’s Mentor unit has revealed the data of its 21% participants for last three years.

National Organization for Women Foundation has censured that much of the data has been lost. The organization has asked for canceling of the J&J’s license and in case of Allergan further close examination should be done.

Earlier, FDA suggested that looking into the outcomes of the products of the two companies the women who undergo breast implants require another surgery after nearly 10 years.

Meanwhile, Mentor stated, “It may have had particularly low response rates because the company made patients participate in the study as a condition of getting an implant, but later changed it to voluntary participation”.